(1R,3S,5R)-2-{2-[3-acetyl-7-methyl-5-(2-methylpyrimidin-5-yl)-1H-indol-1-yl]acetyl}-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide
Structure Info
- Chemspace ID
- CSSB20465147334 (In-Stock Building Blocks)
- MFCD
- MFCD11226372
- IUPAC Name
- (1R,3S,5R)-2-{2-[3-acetyl-7-methyl-5-(2-methylpyrimidin-5-yl)-1H-indol-1-yl]acetyl}-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide
- Mol formula
- C31H31BrN6O3
- Mol weight
- 616 Da
- Catalog Number(s)
- AA02F2IN, AG02F2LF, BO62235, HY-163684, ST02F427, T88259, TX02F3R3
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.7
- Heavy atoms count
- 41
- Rotatable bond count
- 6
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.354
- Polar surface area (Å)
- 110
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB20465147334
Items Overall 9 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 7 days | United States To: | 98 | 1 mg | 457.60 | |
| 1st Scientific LLC | 7 days | United States To: | 98 | 5 mg | 1,084.60 | |
| 1st Scientific LLC | 7 days | United States To: | 98 | 10 mg | 1,711.60 | |
Description: Zoracopan; CAS: 2243483-63-6 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 531.30 | |
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 1,259.25 | |
| A2B Chem | 12 days | United States To: | 98 | 10 mg | 1,987.20 | |
Description: Zoracopan; CAS: 2243483-63-6 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 469.70 | |
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 1,117.60 | |
| 10X CHEM | TBD | United States To: | 98 | 10 mg | 1,764.40 | |
Description: Zoracopan; CAS: 2243483-63-6 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of (1R,3S,5R)-2-{2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl]acetyl}-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide - CSSB06354209293](/st/structure/200/04b531ffa507dcdc79d7177b13a5a383/CC%2528%253DO%2529c1nn%2528CC%2528%253DO%2529N2%255BC%2540%2540H%255D3C%255BC%2540%255D3%2528C%2529C%255BC%2540H%255D2C%2528%253DO%2529Nc2nc%2528Br%2529ccc2C%2529c2ccc%2528cc12%2529-c1cnc%2528C%2529nc1.png)
![Chemical structure of 1-{2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl]acetyl}-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide - CSSB02515421884](/st/structure/200/a7d8f0e99515fe468344296d391ca4c5/CC%2528%253DO%2529C1%253DNN%2528CC%2528%253DO%2529N2CC%2528F%2529CC2C%2528%253DO%2529NC2%253DCC%253DCC%2528Br%2529%253DN2%2529C2%253DCC%253DC%2528C%253DC12%2529C1%253DCN%253DC%2528C%2529N%253DC1.png)
![Chemical structure of (1R,3S,5R)-2-{2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl]acetyl}-N-(6-bromopyridin-2-yl)-2-azabicyclo[3.1.0]hexane-3-carboxamide - CSSB03437848097](/st/structure/200/63d242adb3beedc0dfb27df2c4ab2088/CC%2528%253DO%2529C1%253DNN%2528CC%2528%253DO%2529N2%255BC%2540%2540H%255D3C%255BC%2540%2540H%255D3C%255BC%2540H%255D2C%2528%253DO%2529NC2%253DCC%253DCC%2528Br%2529%253DN2%2529C2%253DCC%253DC%2528C%253DC12%2529C1%253DCN%253DC%2528C%2529N%253DC1.png)
![Chemical structure of (2S,4R)-1-{2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl]acetyl}-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide - CSSB00161116185](/st/structure/200/35db48e3659133246f1295b871914867/CC%2528%253DO%2529C1%253DNN%2528CC%2528%253DO%2529N2C%255BC%2540H%255D%2528F%2529C%255BC%2540H%255D2C%2528%253DO%2529NC2%253DCC%253DCC%2528Br%2529%253DN2%2529C2%253DCC%253DC%2528C%253DC12%2529C1%253DCN%253DC%2528C%2529N%253DC1.png)


![Chemical structure of N-(2-{[(6-bromopyridin-3-yl)carbamoyl]amino}ethyl)-N-methylacetamide - CSSB21432513901](/st/structure/200/304cb4c9994fb8e25bc08aebd3f1fd79/CN%2528CCNC%2528%253DO%2529NC1%253DCN%253DC%2528Br%2529C%253DC1%2529C%2528C%2529%253DO.png)
